Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Ye Zhang, Chun-Qiu Hao et al.|Signal Transduction and Targeted Therapy|2021Cited by 66
CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβRuo Chen, Zhi‐Nan Chen|Cellular and Molecular Immunology|2020Cited by 29
CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinomaRuo Chen, Hong‐Yong Cui|Cancer Cell International|2016Cited by 7